Log in to save to my catalogue

Direct oral anticoagulants: a review on the current role and scope of reversal agents

Direct oral anticoagulants: a review on the current role and scope of reversal agents

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2289577540

Direct oral anticoagulants: a review on the current role and scope of reversal agents

About this item

Full title

Direct oral anticoagulants: a review on the current role and scope of reversal agents

Publisher

New York: Springer US

Journal title

Journal of thrombosis and thrombolysis, 2020-02, Vol.49 (2), p.271-286

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

New guideline recommendations prefer direct oral anticoagulants (DOACs) over warfarin in DOAC-eligible patients with atrial fibrillation and patients with venous thromboembolism. As expected with all antithrombotic agents, there is an associated increased risk of bleeding complications in patients receiving DOACs that can be attributed to the DOAC...

Alternative Titles

Full title

Direct oral anticoagulants: a review on the current role and scope of reversal agents

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2289577540

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2289577540

Other Identifiers

ISSN

0929-5305

E-ISSN

1573-742X

DOI

10.1007/s11239-019-01954-2

How to access this item